Skip to search formSkip to main contentSkip to account menu

Human Papillomavirus 16 E7 Peptide

Known as: HPV-16 E7, HPV-16 E7 Peptide, HPV16 E7 
A peptide vaccine consisting of amino acids 12 through 20 of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7… 
National Institutes of Health

Related topics

Related topics

3 relations
NCIt Antineoplastic Agent Terminologyhuman papillomavirus 16 E7 peptide/PADRE 965.10oncogene protein E7, Human papillomavirus type 16

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems
BackgroundCervical cancer is the second-most-common cause of malignancies in women worldwide, and the oncogenic activity of the… 
Highly Cited
2007
Highly Cited
2007
Anti-cancer activity of plant-produced HPV16 E7 vaccine.
Highly Cited
2004
Highly Cited
2004
CD4+CD25+ Regulatory T Cells That Secrete TGFβ and IL-10 Are Preferentially Induced by a Vaccine Vector
CD4+CD25+ T cells generated in a vaccine scenario can play a critical role in limiting antitumor therapy, thus having widespread… 
Highly Cited
2001
Highly Cited
2001
Therapeutic potential of protein and adjuvant vaccinations on tumour growth.
Highly Cited
2000
Highly Cited
2000
Immunotherapy of a human papillomavirus (HPV) type 16 E7‐expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette–Guérin (BCG) hsp65 and HPV16 E7
Human papillomavirus type 16 (HPV16) infection has been linked to the development of cervical and anal dysplasia and cancer. One… 
Highly Cited
1997
Highly Cited
1997
Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein
Cells expressing human papillomavirus type 16 (HPV-16) E7, similar to those which express HPV-16 E6, are resistant to a p53… 
1994
1994
A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
The human papillomavirus type 16 (HPV-16) E7 oncoprotein shares structural and functional similarity with the adenovirus (Ad) E1A… 
Highly Cited
1992
Highly Cited
1992
Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16.
We have determined nucleotide sequences of the E7 open reading frame (ORF) of human papillomavirus type 16 (HPV-16) isolates… 
Highly Cited
1991
Highly Cited
1991
Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences
Differences in the biological characteristics of the high-risk human papillomavirus type 16 (HPV-16) and the low-risk HPV-6 E7… 
Highly Cited
1990
Highly Cited
1990
Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)